A mare's fertility depends on proper blood flow to the uterus and
ovaries. Adequate blood supply to the reproductive organs is essential
in order for a mare to become pregnant. A variety of conditions can
deplete a chemical called nitric oxide, which is needed to maintain
healthy blood flow to the uterus and ovaries.
FertilAid-for-Mares™ is a nutritional supplement that is designed to
promote blood flow to a mare's uterus and ovaries by supporting
production of nitric oxide. Additionally, FertilAid-for-Mares™ supplies
plant-derived estrogens and progesterone to support healthy functioning
of a mare’s reproductive system.
IMPORTANT:
Anti-inflammatory drugs such as Banamine or "Bute" (phenylbutazone),
and certain herbs block formation of nitric oxide. They will inhibit FertilAid™
effectiveness.
All anti-inflammatory drugs and all other supplements are to be stopped
for at least the first 4-weeks of using FertilAid™.
These instructions must be followed for the product to work.
Nitric oxide is needed for proper functioning of all aspects of a mare’s
reproductive system. Ovulation, implantation of an embryo, and
activation of a fertilized egg all require sufficient levels of nitric
oxide. Nitric oxide dilates blood vessels, increasing blood flow to the
uterus and ovaries.
Insufficient production of nitric oxide can result in decreased blood
flow to a mare’s reproductive organs. This can interfere with the
production of estrogen and progesterone and all other phases of the
reproductive process.
Click here to learn
why the Nobel Prize was awarded for research on nitric oxide.
During sexual activity, stress, or intense exercise a horse's body uses
up large amounts of nitric oxide. To promote fertility in a mare it is
essential to support production of nitric oxide to replenish what is
depleted.
FertilAid-for-Mares™ is a nutritional supplement that is designed to
promote fertility in mares by supporting production of nitric oxide.
Nitric oxide is synthesized in the body from its nutrient precursor, the
amino acid arginine. Attempts to increase nitric oxide production by
administering large quantities of arginine have met with limited
success. Additionally, administering substantial amounts of arginine may
have undesirable side effects, either through stimulating insulin
release or by affecting other mechanisms.
There has been a need for a way to increase the amount of nitric oxide
produced within the body using relatively small doses of arginine.
Achieving these previously unattainable results was made possible
through the development of a proprietary product formulation
methodology, known as NPS™.
